Mr Perreault was the CEO and managing director of CSL from 2013 to 2023, leading the organisation to become the fifth largest biotechnology company in the world.
-
Latest News
More evidence backs the use of weight-loss therapies
Eli Lilly Australia and New Zealand associate vice president of the company's cardiometabolic health business unit, Kelly Frankel, said, "SURMOUNT-5 answers a burning question for doctors and their chronic weight management patients.”
-
Latest News Former CSL CEO Paul Perreault appointed strategic adviser to Microbio December 5, 2024
-
Latest News Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective, December 6, 2024Advara HeartCare, the world’s largest single group of cardiologists, has joined forces with Novartis and TerryWhite Chemmart to form The Heart Health Collective.
-
BioPharma Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing December 6, 2024"I am deeply thankful to our First Nations Advisors for all their time and wisdom, trust and vouching," said Leigh Simmonds, Pfizer Australia RAP Champion and senior manager for patient advocacy.
-
Latest News Australians rank access to affordable healthcare as second most important priority December 4, 2024According to the results of a new survey commissioned by Medicines Australia, around one in six Australians have been unable to pay for needed medical services.
-
Latest News Moderna opens first commercial-scale mRNA manufacturing facility in Southern Hemisphere December 4, 2024Moderna's government-backed mRNA manufacturing facility has officially opened in Melbourne as the only one of its type in the Southern Hemisphere.
-
Latest News Greens announce plan to make contraception more widely accessible December 4, 2024“We are in a cost-of-living crisis and in the face of financial stress and gender inequality, the Greens will take to the election a commitment to provide women with free access to contraceptives," said Senator Larissa Waters.
-
Latest News ChatGPT would have produced more human responses than these committees December 5, 2024In their written responses to the recommendations, the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee have blithely ignored these community concerns in that Marie-Antoinette 'let them eat cake' way.
-
Latest News London Agency bolsters public affairs team with crossbench experience December 4, 2024London Agency has expanded its government affairs offering by recruiting former crossbench staffer Kaya Hill.
-
Latest News These responses aim to poison the well for the proponents of change December 4, 2024The most insidious aspect of their responses is the effect, which is to create a public barrier against meaningful reform, and means the health minister and their ministerial colleagues will need to go against committees they generally eulogise to deliver the change wanted by so many stakeholders. Frankly, who cares what these servants of the system think?
-
Latest News Advisory committees less than enthusiastic about faster patient access to innovation December 4, 2024The two advisory committees have delivered less than enthusiastic support for faster access to new health technologies in their responses to the HTA review.
-
Latest News PBAC supports prioritising submissions in its response to HTA review December 4, 2024Its response was delivered to Health Minister MarkButler in October. Its support for a prioritisation system coincided with the decision to defer the evaluation of dozens of submissions to its March 2025 meeting.
-
Latest News Half of Australians live with chronic conditions, with over a third forced to leave jobs as a result December 4, 2024A new report commissioned by AbbVie has found that of the one in two Australians living with a chronic health condition, over one-third have left a job due to their condition.
-
Latest News 'We are very unhappy that we were not consulted as it is an expectation' December 3, 2024MA has restated its disappointment at the health department's failure to consult on the attempt to defer submissions from consideration at the March PBAC meeting following the release of advice that shows officials advised Mark Butler it was "critical" to "mitigate" the reputational risks to the government.
-
Latest News Albanese Government launches review of Australia’s research and development December 2, 2024AusBiotech CEO Rebekah Cassidy expressed support for the review, emphasising the need for a unified approach to enhance Australia's R&D ecosystem.
-
Latest News Pharmac minister celebrates increase in access to medicines following budget boost December 2, 2024“We want to build a world-class health system, and that requires access to world-class medicines," said New Zealand's Associate Health Minister with responsibility for Pharmac, David Seymour,
-
Latest News People might debate whether some responses misled the Senate December 2, 2024"To be clear, the first time you officially notified the minister or his office that there was a potential problem with the capacity of the March 2025 PBAC meeting was 9 October?" asked the shadow health minister. We now know that the official's response, "That's correct", was incorrect.
-
Latest News PBS listing of Bayer's endometriosis treatment breaks 30-year drought December 2, 2024"Women are suffering unnecessarily. They’re having their experiences dismissed, being called hysterical and accused of drug shopping. Women’s pain is real and it’s time we stop telling women to just suck it up," said Health Minister Mark Butler.
-
Latest News Publication of ministerial advice raises questions about the evidence given at Senate Estimates November 29, 2024Documents tabled in the Senate today raised serious questions about the information provided on PBAC deferrals at Senate Estimates. The advice to Mark Butler indicates the committee's chair may have been indirectly involved in formulating the plan, that the department is legally required to evaluate submissions lodged for March regardless of capacity constraints, and that officials did not consult the industry as directed.
Australian Biotech
-
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio
December 5, 2024 -
Anatara provides irritable bowel syndrome clinical trial update
December 4, 2024 -
Digital health company Adherium secures R&D loan facility
December 4, 2024 -
Alterity Therapeutics completes last patient visit in ATH434-201 trial in multiple system atrophy
December 4, 2024 -
Albanese Government launches review of Australia’s research and development
December 2, 2024
Other Health
-
NSW government backs down on health tax in new agreement with health funds
December 2, 2024 -
Ramsay Health Care and Bupa join forces to develop our next generation of nurses
November 19, 2024 -
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024 -
'Australia’s child vaccination rates are world-leading. Our adult rates are not.'
August 19, 2024
Latest Video
New Stories
-
Novartis partners with Advara HeartCare and TerryWhite Chemmart to launch Heart Health Collective,
December 6, 2024 - - Latest News -
Pfizer Australia launches Innovate Reconciliation Action Plan to advance equitable access to health and wellbeing
December 6, 2024 - - BioPharma -
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio
December 5, 2024 - - Latest News -
More evidence backs the use of weight-loss therapies
December 5, 2024 - - Latest News -
ChatGPT would have produced more human responses than these committees
December 5, 2024 - - Latest News -
Anatara provides irritable bowel syndrome clinical trial update
December 4, 2024 - - Australian Biotech -
Digital health company Adherium secures R&D loan facility
December 4, 2024 - - Australian Biotech